Ευαγγελία Χαρμανδάρη, MD, MSc, PhD, MRCP(UK), CCST(UK)
Καθηγήτρια Παιδιατρικής - Παιδιατρικής και Εφηβικής Ενδοκρινολογίας
Ευαγγελία Χαρμανδάρη, MD, MSc, PhD, MRCP(UK), CCST(UK)
Καθηγήτρια Παιδιατρικής - Παιδιατρικής και Εφηβικής Ενδοκρινολογίας
Δημοσιεύσεις
Δρ. Ευαγγελία Χαρμανδάρη
MD, MSc, PhD, MRCP(UK), CCST(UK)
Καθηγήτρια Παιδιατρικής - Παιδιατρικής και Εφηβικής Ενδοκρινολογίας
Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών
Α' Παιδιατρική Κλινική, Νοσοκομείο Παίδων "Η Αγία Σοφία"Δημοσιεύσεις σε Διεθνή Περιοδικά του SCI
Στην παρούσα σελίδα παρουσιάζεται σε αντίστροφη χρονολογική σειρά ο κατάλογος των δημοσιεύσεων. Περιοδικά με Κριτές
2019
106. Stefa A, Lamprokostopoulou A, Briana DD, Kontogeorgou A, Papageorgiou I, Malamitsi-Puchner A, Tsitsilonis O, Gagos S, Charmandari E. The effect of intrauterine growth on leukocyte telomere length at birth. J Matern Fetal Neonatal Med. 2019; 32(23): 3948-3953.
105. Arellano-Orden E, Bacopoulou F, Baicus C, Bonfrate L, Broadbent J, Buechler C, Carbone F, Charmandari E, Davis GR, Dullaart RPF, Efthymiou V, Goeser F, Goswami N, Jong GP, Lichtenauer M, Liou YS, Lutz P, Maeng M, Mert GÖ, Mert KU, Montecucco F, Ndrepepa G, Olesen KKW, Oliveira P, Perton FG, Portincasa P, Rodriguez-Panadero F, Schernthaner C, Schutte R. Research update for articles published in EJCI in 2017. Eur J Clin Invest. 2019; 49(10): e13163.
104. Gray LJ, Brady EM, Albaina O, Edwardson CL, Harrington D, Khunti K, Miksza J, Raposo JF, Smith E, Vazeou A, Vergara I, Weihrauch-Blüher S, Davies MJ; PRE-STARt Collaborative (Charmandari E). Evaluation and refinement of the PRESTARt tool for identifying 12-14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study. BMC Endocr Disord. 2019; 19(1): 79.103. Bangalore Krishna K, Fuqua JS, Rogol AD, Klein KO, Popovic J, Houk CP, Charmandari E, Lee PA. Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium. Horm Res Paediatr. 2019 Jul 18:1-16. doi: 10.1159/000501336.
102. Nicolaides NC, Polyzos A, Koniari E, Lamprokostopoulou A, Papageorgiou I, Golfinopoulou E, Papathanasiou C, Sertedaki A, Thanos D, Chrousos GP, Charmandari E Transcriptomics in Tissue Glucocorticoid Sensitivity. Eur J Clin Invest. 2019 May 15:e13129. doi: 10.1111/eci.13129.
101. Moschonis G, Michalopoulou M, Tsoutsoulopoulou K, Vlachopapadopoulou E, Michalacos S, Charmandari E, Chrousos GP, Manios Y. Assessment of the Effectiveness of a Computerised Decision-Support Tool for Health Professionals for the Prevention and Treatment of Childhood Obesity. Results from a Randomised Controlled Trial. Nutrients. 2019 Mar 26;11(3). pii: E706. doi: 10.3390/nu11030706.
100. Farakla I, Koui E, Arditi J, Papageorgiou I, Bartzeliotou A, Papadopoulos GE, Mantzou A, Papathanasiou C, Dracopoulou M, Papastamataki M, Moutsatsou P, Papassotiriou I, Chrousos GP, Charmandari E. Effect of Honey on Glucose and Insulin Concentrations in Obese Girls Eur J Clin Invest. 2019 Feb;49(2):e13042. doi: 10.1111/eci.13042.
99. Polytarchou A, Katsouli G, Tsaoussoglou M, Charmandari E, Kanaka-Gantenbein C, Chrousos G, Kaditis AG. Obstructive events in children with Prader-Willi syndrome occur predominantly during rapid eye movement sleep. Sleep Med. 2019 Feb;54:43-47. doi: 10.1016/j.sleep.2018.09.026.
2018
98. Katsarou MS, Karathanasopoulou A, Andrianopoulou A, Desiniotis V, Tzinis E, Dimitrakis E, Lagiou M, Charmandari E, Aschner M, Tsatsakis AM, Chrousos GP, Drakoulis N.. Beta 1, Beta 2 and Beta 3 Adrenergic Receptor Gene Polymorphisms in a Southeastern European Population. Front Genet. 2018 Nov 28;9:560. doi: 10.3389/fgene.2018.00560. eCollection 2018.
97. Kyritsi EM, Sertedaki A, Charmandari E, Chrousos GP. Familial or Sporadic Adrenal Hypoplasia Syndromes. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. 2018 Oct 22.
96. Adlbrecht C, Blanco-Verea A, Bouzas-Mosquera MC, Brion M, Burtscher M, Carbone F, Chang TT, Charmandari E, Chen JW, Correia-Costa L, Dullaart RPF, Eleftheriades M, Fernandez-Fernandez B, Goliasch G, Gremmel T, Groeneveld ME, Henrique A, Huelsmann M, Jung C, Lichtenauer M, Montecucco F, Nicolaides NC, Niessner A, Palmeira C, Pirklbauer M, Sanchez-Niño MD, Sotiriadis A, Sousa T, Sulzgruber P, van Beek AP, Veronese N, Winter MP, Yeung KK. Research update for articles published in EJCI in 2016. Eur J Clin Invest. 2018 Oct;48(10):e13016. doi: 10.1111/eci.13016. Epub 2018 Sep 16. Review.
95. Emmanouil CC, Pervanidou P, Charmandari E, Darviri C, Chrousos GP. The effectiveness of a health promotion and stress-management intervention program in a sample of obese children and adolescents. Hormones (Athens). 2018 Sep;17(3):405-413. doi: 10.1007/s42000-018-0052-2. Epub 2018 Aug 11.
94. Stefa A, Lamprokostopoulou A, Briana DD, Kontogeorgou A, Papageorgiou I, Malamitsi-Puchner A, Tsitsilonis O, Gagos S, Charmandari E The effect of intrauterine growth on leukocyte telomere length at birth. J Matern Fetal Neonatal Med. 2018 May 20:1-161. doi: 10.1080/14767058.2018.1479392.
93. Kassari P, Papaioannou P, Billiris A, Karanikas H, Eleftheriou S, Thireos E, Manios Y, Chrousos GP, Charmandari E Electronic Registry for the Management of Childhood Obesity in Greece Eur J Clin Invest. 2018 Jan 11. doi: 10.1111/eci.12887.
2017
92. Papageorgiou L, Vlachakis C, Dragoumani K, Raftopoulou S, Brouzas D, Nicolaides NC, Chrousos GP, Charmandari E, Megalooikonomou V, Vlachakis D. HCV genetics and genotypes dictate future antiviral strategies J Mol Biochem. 2017;6:33-40. Epub 2017 Dec 10.
91. Al-Daghri NM et al. (including Charmandari E.) Research update for articles published in EJCI in 2015 Eur J Clin Invest. 2017 Oct;47(10):775-788. doi: 10.1111/eci.12819.
90. Bacopoulou F, Kolias E, Efthymiou V, Antonopoulos CN, Charmandari E. Vitamin D predictors in polycystic ovary syndrome: A meta-analysis. Eur J Clin Invest. 2017 Oct;47(10):746-755. doi: 10.1111/eci.12800. Epub 2017 Sep 7.
89. Nicolaides NC, Kino T, Roberts ML, Katsantoni E, Sertedaki A, Moutsatsou P, Psarra AG, Chrousos GP, Charmandari E. The Role of S-Palmitoylation of the Human Glucocorticoid Receptor (hGR) in Mediating the Nongenomic Glucocorticoid Actions. J Mol Biochem. 2017;6(1):3-12. Epub 2017 Apr 15.
88. Nicolaides NC, Charmandari E. Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes. Hormones (Athens). 2017 Apr;16(2):124-138. doi: 10.14310/horm.2002.1728. Review.
87. Nicolaides NC, Charmandari E., Kino T, Chrousos GP. Stress-Related and Circadian Secretion and Target Tissue Actions of Glucocorticoids: Impact on Health. Front Endocrinol (Lausanne). 2017 Apr 28;8:70. doi: 10.3389/fendo.2017.00070. eCollection 2017. Review.
86. Kyritsi EM, Koltsida G, Farakla I, Papanikolaou A, Critselis E, Mantzou E, Zoumakis E, Kolaitis G, Chrousos GP, Charmandari E. Psychological vulnerability to stress in carriers of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hormones (Athens). 2017 Jan;16(1):42-53. doi: 10.14310/horm.2002.1718.
85. Vardas K, Ilia S, Sertedaki A, Charmandari E., Briassouli E, Goukos D, Apostolou K, Psarra K, Botoula E, Tsagarakis S, Magira E, Routsi C, Stratakis CA, Nanas S, Briassoulis G. Increased glucocorticoid receptor expression in sepsis is related to heat shock proteins, cytokines, and cortisol and is associated with increased mortality. Intensive Care Med Exp. 2017 Dec;5(1):10. doi: 10.1186/s40635-017-0123-8.
84. Stavrou S, Nicolaides NC, Critselis E, Darviri C, Charmandari E., Chrousos GP. Pediatric Stress: From Neuroendocrinology to Contemporary Disorders. Eur J Clin Invest. 2017 Mar;47(3):262-269. doi: 10.1111/eci.12724. Review.
2016
83. Sertedaki A, Markou A, Vlachakis D, Kossida S, Campanac E, Hoffman DA, Sierra ML, Xekouki P, Stratakis CA, Kaltsas G, Piaditis GP, Chrousos GP, Charmandari E. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion. Clin Endocrinol (Oxf). 2016 Dec;85(6):845-851. doi: 10.1111/cen.13132.
82. Kassi E, Semaniakou A, Sertedaki A, Evangelopoulos ME, Kazazoglou T, Kominakis A, Sfagos C, Charmandari E, Chrousos GP, Moutsatsou P. Sequencing analysis of the human glucocorticoid receptor (NR3C1) gene in multiple sclerosis patients. J Neurol Sci. 2016 Apr 15;363:165-9. doi: 10.1016/j.jns.2016.02.054. Epub 2016 Feb 23.
81. Hurt DE, Suzuki S, Mayama T, Charmandari E, Kino T. Structural Analysis on the Pathologic Mutant Glucocorticoid Receptor Ligand-binding Domains. Mol Endocrinol. 2016 Feb;30(2):173-88. doi: 10.1210/me.2015-1177. Epub 2016 Jan 8.
80. Nicolaides NC, Skyrla E, Vlachakis D, Psarra AM, Moutsatsou P, Sertedaki A, Kossida S, Charmandari E. Functional characterization of the hGRαT556I causing Chrousos syndrome. Eur J Clin Invest. 2016 Jan;46(1):42-9. doi: 10.1111/eci.12563.
79. Lee PA, Nordenström A, Houk CP, Ahmed SF, Auchus R, Baratz A, Baratz Dalke K, Liao LM, Lin-Su K, Looijenga LH 3rd, Mazur T, Meyer-Bahlburg HF, Mouriquand P, Quigley CA, Sandberg DE, Vilain E, Witchel S; Global DSD Update Consortium. Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care. Horm Res Paediatr. 2016;85(3):158-80. doi: 10.1159/000442975. Epub 2016 Jan 28.
78. Nicolaides N, Lamprokostopoulou A, Sertedaki A, Charmandari E. Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance. Hormones (Athens). 2016 Jan;15(1):23-34. doi: 10.14310/horm.2002.1660. Review.
77. Stavrou S, Nicolaides NC, Papageorgiou I, Papadopoulou P, Terzioglou E, Chrousos GP, Darviri C, Charmandari E. The effectiveness of a stress-management intervention program in the management of overweight and obesity in childhood and adolescence. J Mol Biochem. 2016;5(2):63-70.
76. Charmandari E., Guan R, Zhang M, Silveira LG, Fan QR, Chrousos GP, Sertedaki AC, Latronico AC, Segaloff DL. Misfolding Ectodomain Mutations of the Lutropin Receptor Increase Efficacy of Hormone Stimulation. Mol Endocrinol. 2016 Jan;30(1):62-76. doi: 10.1210/me.2015-1205.
2015
75. Nicolaides NC, Lamprokostopoulou A, Polyzos A, Kino T, Katsantoni E, Triantafyllou P, Christophoridis A, Katzos G, Dracopoulou M, Sertedaki A, Chrousos GP, Charmandari E. Transient Generalized Glucocorticoid Hypersensitivity. Eur J Clin Invest. 2015 Dec;45(12):1306-15. doi: 10.1111/eci.12554. Epub 2015 Nov 20.
74. Nicolaides NC, Geer EB, Vlachakis D, Roberts ML, Psarra AM, Moutsatsou P, Sertedaki A, Kossida S, Charmandari E. A novel mutation of the hGR gene causing Chrousos syndrome. Eur J Clin Invest. 2015 Aug;45(8):782-91. doi: 10.1111/eci.12470. Epub 2015 Jul 14.
73. Markou A, Sertedaki A, Kaltsas G, Androulakis II, Marakaki C, Pappa T, Gouli A, Papanastasiou L, Fountoulakis S, Zacharoulis A, Karavidas A, Ragkou D, Charmandari E, Chrousos GP, Piaditis GP. Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension. J Clin Endocrinol Metab. 2015 Aug;100(8):2857-64. doi: 10.1210/jc.2015-1268. Epub 2015 May 14.
72. Nicolaides NC, Charmandari E Chrousos Syndrome: From Molecular Pathogenesis to Therapeutic Management. Eur J Clin Invest. 2015 May;45(5):504-14. doi: 10.1111/eci.12426. Epub 2015 Mar 23
71. Hindmarsh PC, Charmandari E Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations. Clin Endocrinol (Oxf). 2015 Apr;82(4):557-61. doi: 10.1111/cen.12653.
70. Nicolaides NC, Kyratzi E, Lamprokostopoulou A, Chrousos GP, Charmandari E Stress, the stress system and the role of glucocorticoids. Neuroimmunomodulation. 2015;22(1-2):6-19. doi: 10.1159/000362736. Epub 2014 Sep 12.
2014
69. Nicolaides NC, Charmandari E, Chrousos GP., Kino T. Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor. BMC Endocr Disord. 2014 Aug 25;14:71. doi: 10.1186/1472-6823-14-
68. Charmandari E, Nicolaides NC, Chrousos GP. Adrenal Insufficiency. Lancet. 2014 Feb 3. pii: S0140-6736(13)61684-0. doi: 10.1016/S0140-6736(13)61684-0.
67. Nicolaides NC, Charmandari E, Chrousos GP., Kino T. Circadian endocrine rhythms: the hypothalamic-pituitary-adrenal axis and its actions.. Ann N Y Acad Sci. 2014 May;1318:71-80. doi: 10.1111/nyas.12464.
66. Nicolaides NC, Roberts ML, Kino T, Braatvedt G, Hurt DE, Katsantoni E, Sertedaki A, Chrousos GP, Charmandari E. A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities.. J Clin Endocrinol Metab. 2014 May;99(5):E902-7. doi: 10.1210/jc.2013-3005.
65. Moschonis G, Kalliora AC, Costarelli V, Papandreou C, Koutoukidis D, Lionis C, Chrousos GP, Manios Y; Healthy Growth Study Group.. (Charmandari E). Identification of lifestyle patterns associated with obesity and fat mass in children: the Healthy Growth Study.. Public Health Nutr. 2014 Mar;17(3):614-24. doi: 10.1017/S1368980013000323.
64. Manios Y, Moschonis G, Papandreou C, Siatitsa PE, Iatridi V, Lidoriki I, Lionis C, Chrousos GP; Healthy Growth Study group. (Charmandari E). Female sex, small size at birth and low family income increase the likelihood of insulin resistance in late childhood: the Healthy Growth Study.. Pediatr Diabetes. 2014 Feb;15(1):41-50. doi: 10.1111/pedi.12052.
63. Androutsos O, Moschonis G, Koumpitski A, Mantzou A, Roma-Giannikou E, Chrousos GP, Manios Y, Kanaka-Gantenbein C; “Healthy Growth Study” Group. (Charmandari E). The correlation of right 2D:4D finger length ratio to the low-grade inflammation marker IL-6 in children. The Healthy Growth Study.. Early Hum Dev. 2014 Jan;90(1):61-5. doi: 10.1016/j.earlhumdev.2013.10.003.
2013
62. Manios Y, Birbilis M, Moschonis G, Birbilis G, Mougios V, Lionis C, Chrousos GP; “Healthy Growth Study” group (Charmandari E). Childhood Obesity Risk Evaluation based on perinatal factors and family sociodemographic characteristics: CORE index. Eur J Pediatr. 2013; 172(4): 551-5.
61. Roberts ML, Kino T, Nicolaides NC, Hurt DE, Katsantoni E, Sertedaki A, Komianou F, Kassiou K, Chrousos GP, Charmandari E. A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD. J Clin Endocrinol Metab. 2013; 98(4): E790-5.
60. Peters CJ, Hill N, Dattani MT, Charmandari E, Matthews DR, Hindmarsh PC. Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapy. Clin Endocrinol (Oxf). 2013; 78(3): 347-51.
59. Charmandari E, Kino T, Chrousos GP. Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity. Endocr Dev. 2013; 24:67-85.
58. Birbilis M, Moschonis G, Mougios V, Manios Y; Healthy Growth Study’ group (Charmandari E). Obesity in adolescence is associated with perinatal risk factors, parental BMI and sociodemographic characteristics. Eur J Clin Nutr. 2013; 67(1): 115-21.
2012
57. Charmandari E, Achermann JC, Carel JC, Soder O, Chrousos GP. Stress response and child health. Sci Signal. 2012; 5(248): mr1.
56. Charmandari E. Primary generalized glucocorticoid resistance and hypersensitivity: the end-organ involvement in the stress response. Sci Signal. 2012; 5(244): pt5.
55. Moschonis G, Chrousos GP, Lionis C, Mougios V, Manios Y; Healthy Growth Study group (Charmandari E). Association of total body and visceral fat mass with iron deficiency in preadolescents: the Healthy Growth Study. Br J Nutr. 2012; 108(4): 710-9.
54. Charmandari E, Sertedaki A, Kino T, Merakou C, Hoffman DA, Hatch MM, Hurt DE, Lin L, Xekouki P, Stratakis CA, Chrousos GP. A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension. J Clin Endocrinol Metab. 2012; 97(8): E1532-9.
2011
53. Galata Z, Moschonis G, Makridakis M, Dimitraki P, Nicolaides NC, Manios Y, Bartzeliotou A, Chrousos GP, Charmandari E. Plasma proteomic analysis in obese and overweight prepubertal children. Eur J Clin Invest. 2011; 41(12): 1275-83.
52. Kino T, Charmandari E, Chrousos GP. Glucocorticoid receptor: implications for rheumatic diseases. Clin Exp Rheumatol. 2011; 29(5 Suppl 68): S32-41.
51. Charmandari E. Primary generalized glucocorticoid resistance and hypersensitivity. Horm Res Paediatr. 2011; 76(3): 145-55.
50. Charmandari E, Chrousos GP, Lambrou GI, Pavlaki A, Koide H, Ng SS, Kino T. Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. PLoS One. 2011; 6(9): e25612.
2010
49. Charmandari E, Kino T. Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes. Eur J Clin Invest. 2010; 40(10): 932-42.
48. Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E. The human glucocorticoid receptor: molecular basis of biologic function. Steroids. 2010; 75(1): 1-12.
2009
47. Charmandari E, Chrousos GP, Kino T. Identification of natural human glucocorticoid receptor (hGR) mutations or polymorphisms and their functional consequences at the hormone-receptor interaction level. Methods Mol Biol. 2009; 590:33-60.
46. Chrousos GP, Kino T, Charmandari E. Evaluation of the hypothalamic-pituitary-adrenal axis function in childhood and adolescence. Neuroimmunomodulation. 2009; 16(5): 272-83.
2008
45. Charmandari E, Ichijo T, Jubiz W, Baid S, Zachman K, Chrousos GP, Kino T. A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression. J Clin Endocrinol Metab. 2008; 93(12): 4963-8.
44. Charmandari E, Kino T, Ichijo T, Chrousos GP. Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab. 2008; 93(5): 1563-72.
2007
43. Charmandari E, Kino T, Ichijo T, Jubiz W, Mejia L, Zachman K, Chrousos GP. A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance. J Clin Endocrinol Metab. 2007; 92(10): 3986-90.
42. Charmandari E, Kino T. Novel causes of generalized glucocorticoid resistance. Horm Metab Res. 2007; 39(6): 445-50.
41. Leong GM, Abad V, Charmandari E, Reynolds JC, Hill S, Chrousos GP, Nieman LK. Effects of child- and adolescent-onset endogenous Cushing syndrome on bone mass, body composition, and growth: a 7-year prospective study into young adulthood. J Bone Miner Res. 2007; 22(1): 110-8.
2006
40. Charmandari E, Chrousos GP. Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? Ann N Y Acad Sci. 2006; 1083:37-53.
39. Kino T, Souvatzoglou E, Charmandari E, Ichijo T, Driggers P, Mayers C, Alatsatianos A, Manoli I, Westphal H, Chrousos GP, Segars JH. Rho family Guanine nucleotide exchange factor Brx couples extracellular signals to the glucocorticoid signaling system. J Biol Chem. 2006; 281(14): 9118-26.
38. Charmandari E, Kino T, Ichijo T, Zachman K, Alatsatianos A, Chrousos GP. Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance. J Clin Endocrinol Metab. 2006; 91(4): 1535-43.
2005
37. Charmandari E, Raji A, Kino T, Ichijo T, Tiulpakov A, Zachman K, Chrousos GP. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. J Clin Endocrinol Metab. 2005; 90(6): 3696-705.
36. Charmandari E, Tsigos C, Chrousos G. Endocrinology of the stress response. Annu Rev Physiol. 2005; 67:259-84.
35. Kino T, De Martino MU, Charmandari E, Ichijo T, Outas T, Chrousos GP. HIV-1 accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of forkhead transcription factors by interfering with their binding to 14-3-3 proteins: potential clinical implications regarding the insulin resistance of HIV-1-infected patients. Diabetes. 2005; 54(1): 23-31.
34. Charmandari E, Chrousos GP, Merke DP. Adrenocorticotropin hypersecretion and pituitary microadenoma following bilateral adrenalectomy in a patient with classic 21-hydroxylase deficiency. J Pediatr Endocrinol Metab. 2005; 18(1): 97-101.
33. Charmandari E, Chrousos GP, Ichijo T, Bhattacharyya N, Vottero A, Souvatzoglou E, Kino T. The human glucocorticoid receptor (hGR) beta isoform suppresses the transcriptional activity of hGRalpha by interfering with formation of active coactivator complexes. Mol Endocrinol. 2005; 19(1): 52-64.
2004
32. Charmandari E, Brook CG, Hindmarsh PC. Classic congenital adrenal hyperplasia and puberty. Eur J Endocrinol. 2004; 151 Suppl 3: U77-82.
31. Weise M, Drinkard B, Mehlinger SL, Holzer SM, Eisenhofer G, Charmandari E, Chrousos GP, Merke DP. Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise. J Clin Endocrinol Metab. 2004; 89(8): 3679-84.
30. Kino T, Liou SH, Charmandari E, Chrousos GP. Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function. Mol Med. 2004; 10(7-12): 80-8.
29. Charmandari E, Kino T, Chrousos GP. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms. Ann N Y Acad Sci. 2004; 1024: 168-81.
28. Charmandari E, Kino T, Chrousos GP. Glucocorticoids and their actions: an introduction. Ann N Y Acad Sci. 2004; 1024: 1-8.
27. Charmandari E, Merke DP, Negro PJ, Keil MF, Martinez PE, Haim A, Gold PW, Chrousos GP. Endocrinologic and psychologic evaluation of 21-hydroxylase deficiency carriers and matched normal subjects: evidence for physical and/or psychologic vulnerability to stress. J Clin Endocrinol Metab. 2004; 89(5): 2228-36.
26. Charmandari E, Kino T, Souvatzoglou E, Vottero A, Bhattacharyya N, Chrousos GP. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype. J Clin Endocrinol Metab. 2004; 89(4): 1939-49.
25. Weise M, Mehlinger SL, Drinkard B, Rawson E, Charmandari E, Hiroi M, Eisenhofer G, Yanovski JA, Chrousos GP, Merke DP. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise. J Clin Endocrinol Metab. 2004; 89(2): 591-7.
24. Chrousos GP, Charmandari E, Kino T. Glucocorticoid action networks--an introduction to systems biology. J Clin Endocrinol Metab. 2004; 89(2): 563-4.
2003
23. Kino T, Charmandari E, Chrousos GP. Basic and clinical implications of glucocorticoid action--focus on development. National Institutes of Health, Bethesda, Maryland, USA. June 17-18, 2003. Introduction and abstracts. Horm Metab Res. 2003; 35(10): 628-48.
22. Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC. Sexual dimorphism in the synchrony of joint growth hormone and cortisol dynamics in children with classic 21-hydroxylase deficiency. J Pediatr Endocrinol Metab. 2003; 16(8): 1119-30.
21. Kino T, De Martino MU, Charmandari E, Mirani M, Chrousos GP. Tissue glucocorticoid resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol. 2003; 85(2-5): 457-67.
20. Roche EF, Charmandari E, Dattani MT, Hindmarsh PC. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report. Clin Endocrinol (Oxf). 2003; 58(5): 589-96.
19. Spoudeas HA, Charmandari E, Brook CG. Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours. Med Pediatr Oncol. 2003; 40(4): 224-9.
18. Charmandari E, Kino T, Souvatzoglou E, Chrousos GP. Pediatric stress: hormonal mediators and human development. Horm Res. 2003; 59(4): 161-79.
2002
17. Kino T, Vottero A, Charmandari E, Chrousos GP. Familial/sporadic glucocorticoid resistance syndrome and hypertension. Ann N Y Acad Sci. 2002; 970: 101-11.
16. Charmandari E, Calis KA, Keil MF, Mohassel MR, Remaley A, Merke DP. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2002; 87(7): 3197-200.
15. Charmandari E, Eisenhofer G, Mehlinger SL, Carlson A, Wesley R, Keil MF, Chrousos GP, New MI, Merke DP. Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2002; 87(7): 3031-7.
14. Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion. J Clin Endocrinol Metab. 2002; 87(5): 2238-44.
13. Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab. 2002; 87(5): 2114-20.
12. Charmandari E, Brook CG, Hindmarsh PC. Why is management of patients with classical congenital adrenal hyperplasia more difficult at puberty? Arch Dis Child. 2002; 86(4): 266-9.
11. Charmandari E, Johnston A, Honour JW, Brook CG, Hindmarsh PC. Treatment with flutamide decreases cortisol clearance: implications for therapy in congenital adrenal hyperplasia. J Pediatr Endocrinol Metab. 2002; 15(4): 435-9.
2001
10. Charmandari E, Dattani MT, Perry LA, Hindmarsh PC, Brook CGD. Kinetics and effect of percutaneous administration of dihydrotestosterone in children. Hormone Research 2001; 56(5-6): 177-181.
9. Charmandari E, Matthews DR, Johnston A, Brook CGD, Hindmarsh PC. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: Is current replacement therapy satisfactory Journal of Clinical Endocrinology & Metabolism 2001; 86(10): 4679-4685.
8. Charmandari E, Pincus SM, Matthews DR, Dennison E, Fall CHD, Hindmarsh PC. Joint growth hormone and cortisol spontaneous secretion is more asynchronous in older females than their male counterparts. Journal of Clinical Endocrinology & Metabolism 2001; 86(7): 3393-3399.
7. Charmandari E, Lichtarowicz-Krynska E, Hindmarsh PC, Aynsley-Green A, Brook CGD. Congenital adrenal hyperplasia: management during critical illness. Archives of Disease in Childhood 2001; 85(1): 26-28.
6. Charmandari E, Hindmarsh PC, Johnston A, Brook CGD. Alterations in cortisol pharmacokinetics at puberty. Journal of Clinical Endocrinology & Metabolism 2001; 86(6): 2701-2708.
5. Charmandari E, Johnston A, Brook CGD, Hindmarsh PC. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia. Journal of Endocrinology 2001; 169(1): 65-70.
4. Charmandari E. Is hydrocortisone clearance 50% slower in the evening than in the morning? Journal of Clinical Endocrinology & Metabolism 2001; 86(2): 948-949.
3. Charmandari E, Meadows N, Patel M, Johnston A, Benjamin N. Plasma nitrate concentrations in patients with infective and non-infective enteritis. Journal of Pediatric Gastroenterology and Nutrition 2001; 32(4): 423-427.
2000
2. Koziell A, Charmandari E, Hindmarsh PC, Scambler P, Brook CGD. Frasier syndrome and the Wilm’s tumour suppressor Gene. Clinical Endocrinology (Oxford) 2000; 52(4): 519-524.
1999
1. Charmandari E, Brook CGD. 20 years of experience in idiopathic central diabetes insipidus. Lancet 1999; 353 (9171): 2212-2213.
Δημοσιεύσεις σε Περιοδικά εκτός SCI
8. Charmandari E. Gender Dysphoria: Consensus Guidelines of the Endocrine Society. Clinicae Paediatricae Universitatis Atheniensis 2018; 68(1): 77-83.
7. Charmandari E. National program on the prevention and management of overweight and obesity in childhood and adolescence. Clinicae Paediatricae Universitatis Atheniensis 2013; 60(2): 131-132.
6. Charmandari E. Prevention and management of obesity in childhood and adolescence. Clinicae Paediatricae Universitatis Atheniensis 2013; 60(1): 50-54.
5. Charmandari E. Chrousos Syndrome. Clinicae Paediatricae Universitatis Atheniensis 2011; 58(4): 293-305.
4. Charmandari E. Precocious Puberty. Pediatriki 2010; 73(3): 81-89.
3. Charmandari E. Glucocorticoids. Pediatriki 2009; 72(3): 161-173.
2. Chrousos GP, Kino T, Charmandari E. Generalized glucocorticoid resistance. European Endocrinology 2008; 4(2): 93-99.
1. Charmandari E. Phytoestrogens and child health. Clinicae Paediatricae Universitatis Atheniensis 2008; 55(3): 252-258.
Δημοσιεύσεις σε Βιβλία
37. Flueck C, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, K Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2018; (in press).
36. Lajic S, Karlsson L, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, K Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2019; (in press).
35. Nicolaides NC, Charmandari E, Chrousos GP. Glucocorticoids-Overview. In: Encyclopedia of Endocrine Diseases. Ilpo Huhtaniemi, Luciano Martini & Andre Lacroix (eds), Elsevier, San Diego, CA, USA; 2018
34. Nicolaides NC, Charmandari E. Adrenal Insufficiency: Etiology and Diagnosis. In: Encyclopedia of Endocrine Diseases. Ilpo Huhtaniemi, Luciano Martini & Andre Lacroix (eds), Elsevier, San Diego, CA, USA; 2017
33. Κάσσαρη Π, Παπαϊωάννου Π, Μπιλλήρης Α, Καρανίκας Χ, Ελευθερίου Σ, Θηραίος Ε, Μανιός Ι, Χρούσος Γ, Χαρμανδάρη Ε. Ηλεκτρονική Διαδικτυακή Εφαρμογή Υγείας: Εθνικό Μητρώο Πρόληψης και Αντιμετώπισης της Υπερβαρότητας και Παχυσαρκίας κατά την Παιδική και Εφηβική Ηλικία στην Ελλάδα. Επίτιμος τόμος προς τιμήν του Ομότιμου Καθηγητή κ. Αναγνωστόπουλου 2017
32. Flueck C, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, K Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2017
31. Nicolaides NC, Lamprokostopoulou A, Sertedaki A, Chrousos GP, Charmandari E. Primary Generalized Glucocorticoid Resistance or Chrousos Syndrome: Allostasis through a Mutated Glucocorticoid Receptor. In: The Hypothalamic Pituitary Adrenal Axis in Health and Disease, Geer E (eds), Springer, New York, NY 10110, USA, 2017; Pages 255-269.
30. Charmandari E, Kyritsi EM, Stratakis C, Sarafoglou K, Chrousos GP. Cushing syndrome in childhood and adolescence. In: Pediatric Endocrinology and Inborn Errors of Metabolism, Sarafoglou K, Hoffmann GF, Roth KS (eds), McGraw Hill, New York, NY 10121, USA; 2017, Part IV, Pages: 561-576.
29. Kyritsi EM, Kourkouti C, Chrousos GP, Charmandari E. Hypercortsolism and Cushing Syndrome. In Biomedical Sciences 2016.
28. van den Akker ELT, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, K Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2016; Pages: 97-112.
27. Νικολαΐδης ΝΧ, Χρούσος ΓΠ, Χαρμανδάρη Ε. Σύνδρομο ́Χρούσος ́: Από τη μοριακή παθογένεια στη διαγνωστική και θεραπευτική προσέγγιση. Στον Επίτιμος τόμος προς τιμήν του Ομότιμου Καθηγητή κ. Εμμανουήλ Καναβάκη, Κίτσιου Σ. & Μαύρου Α. (εκδότες), Broken Hill Publishers Ltd, Nicosia, Cyprus, 2016; Σελίδες: 553-564.
26. van den Akker ELT, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, K Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2015; Pages: 97-114.
25. Nicolaides NC, Charmandari E, Chrousos GP. The hypothalamic-pituitary-adrenal axis in human health and disease. In: Introduction to Translational Cardiovascular Research, Cokkinos D (ed), 2015, Pages: 91-107.
24. van den Akker ELT, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, K Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2014; 97-114.
23. Nicolaides NC, Charmandari E, Chrousos GP. Adrenal Steroid Hormone Secretion: Physiologic and Endocrine Aspects. In Encyclopedia of Human Biology, 3rd edition, 2014
22. Van den Akker ELT, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, Ken Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2013; Pages: 97-111.
21. Pervanidou P, Charmandari E, Chrousos GP. Endocrine aspects of childhood obesity. Current Pediatric Reports, Ronald Kleinman (Editor), Springer Science & Business Media, New York, NY, USA; 2012 (in press).
20. Charmandari E, Chrousos GP. The Effect of Stress on the Hypothalamic-pituitary-adrenal Axis: An Update. In Neuroendocrine Disorders in Children, Mehul T. Dattani (Editor), McKeith Press, London, UK; 2012 (in press).
19. Charmandari E, Chrousos GP. Primary Generalized Glucocorticoid Resistance or Chrousos syndrome. In Oxford Desk Reference - Endocrinology, Helen Turner, Ashley Grossman and Richard Eastell (eds), Oxford University Press, Oxford, UK; 2012 (in press).
18. Charmandari E, Kino T, Chrousos GP. Primary Generalized Familial and Sporadic Glucocorticoid Resistance (Chrousos syndrome) and Hypersensitivity. In Endocrine Development, Maghnie M (ed); 2012 (in press).
17. Van den Akker ELT, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, Ken Ong, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2012; Pages: 99-115.
16. Charmandari E, Kino T, Chrousos GP. Primary Generalized Glucocorticoid Resistance and Hypersensitivity. In Endocrine Hypertension, Koch CA, Chrousos GP (eds), Springer, Humana Press, USA; 2011 (in press).
15. Van den Akker ELT, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, JC Carel, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2011; Pages 99-119.
14. Charmandari E. Delayed puberty. In Primary medical care for children and adolescents. Chrysanthopoulos C (eds) 2011; (in press).
13. Charmandari E. Precocious puberty. In Primary medical care for children and adolescents. Chrysanthopoulos C (eds) 2011; (in press).
12. Kino T, Charmandari E, Chrousos GP. Disorders of the hypothalamic-pituitary- adrenocortical system. In Handbook of Neuroendocrinology. George Fink, Donald Pfaff and Jon Levine (eds), Elsevier, San Diego, California, USA, 2011 (in press).
11. Van den Akker ELT, Charmandari E. Adrenals. In Yearbook of Pediatric Endocrinology, JC Carel, Z Hochberg (eds), Karger AG, Basel, Switzerland, 2010; Pages 99-118.
10. Charmandari E, Kino T, Chrousos GP. Glucocorticoids. In Neonatal and Pediatric Pharmacology, 4th Edition. Yaffe SJ and Aranda JV (eds), Lippincott Williams & Wilkins, Philadelphia, PA, USA. 2010; Chapter 51, pages: 760-772.
9. Charmandari E, Chrousos GP, Kino T. Identification of Natural Human Glucocorticoid Receptor (hGR) Mutations or Polymorphisms and their Functional Consequences at the Hormone-Receptor Interaction Level. In Methods in Molecular Biology - Molecular Endocrinology: A Comprehensive Guide to Current Methodologies. Sarge OP and Curry T (eds), Humana Press, USA, 2009; Chapter 3, pages 33-60.
8. Charmandari E. Puberty and Adrenarche. In Reproductive Endocrinology. Mastorakos G (eds) 2008; Chapter 21 (in press).
7. Charmandari E, Kino T, Chrousos GP. Generalized Glucocorticoid Insensitivity: Clinical Phenotype and Molecular Mechanisms. In Overcoming Steroid Insensitivity in Respiratory Disease. Adcock I and Chung F (eds), John Wiley & Sons, Ltd, United Kingdom, 2008; Chapter 5, pages 73-87.
6. Charmandari E, Chrousos GP, Merke DP. Classic Congenital Adrenal Hyperplasia. In Adrenal Glands: Diagnostic Aspects and Surgical Therapy. Linos DA and van Heerden JA (eds) Springer-Verlag, Germany, 2005; Chapter 10, pages 101-114.
5. Kino T, Charmandari E, Chrousos GP. Glucocorticoid action - Basic and clinical implications. Annals of the New York Academy of Sciences 2004; Volume 1024; pages 1-221.
4. Charmandari E, Kino T, Chrousos GP. Glucocorticoids. In Neonatal and Pediatric Pharmacology, 3rd Edition. Yaffe SJ and Aranda JV (eds), Lippincott Williams & Wilkins, Philadelphia, PA, USA. 2004; pages 713-726.
3. Charmandari E, Chrousos GP. Glucocorticoids, Overview. In Encyclopedia of Endocrine Diseases. Luciano Martini (ed), Elsevier, San Diego, CA, USA. 2004; pages 253-259.
2. Charmandari E, Kino T, Chrousos GP. Glucocorticoid Receptor. In Encyclopedia of Endocrine Diseases. Luciano Martini (ed), Elsevier, San Diego, CA, USA. 2004; pages 229-234.
1..Charmandari E, Chrousos GP. Adrenal Insufficiency. In Encyclopedia of Endocrine Diseases. Luciano Martini (ed), Elsevier, San Diego, CA, USA. 2004; pages 75-80.
Δημοσιεύσεις σε Ηλεκτρονικά Βιβλία
18. Nicolaides NC, Kino T, Chrousos GP, Charmandari E. Adrenal Insufficiency. Leslie DeGroot (ed). 2017; www.Endotext.org.
17. Nicolaides NC, Kino T, Chrousos GP, Charmandari E. Primary Generalized Glucocorticoid Resistance or Chrousos syndrome. Leslie DeGroot (ed). 2017; www.Endotext.org.
16. Nicolaides NC, Charmandari E, Chrousos syndrome. In Bio: Bio Health. M. Theodorakis (ed). 2015; www.biomagazine.gr (http://www.biomagazine.gr/index.php/site/article/39/2/BIO%20Health/to-syndromo-xroysos- kai-h-therapeytikh-proseggish)
15. Kyritsi EM, Sertedaki A, Chrousos GP, Charmandari E. Familial or sporadic adrenal hypoplasia syndromes. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2015; www.Endotext.org.
14. Nicolaides NC, Kino T, Chrousos GP, Charmandari E. Primary Generalized Glucocorticoid Resistance or Chrousos syndrome. Leslie DeGroot (ed). 2014; www.Endotext.org.
13. Nicolaides NC, Chrousos GP, Charmandari E. Adrenal Insufficiency. Leslie DeGroot (ed). 2013; www.Endotext.org.
12. Charmandari E, Kino T, Chrousos GP. Primary Generalized Glucocorticoid Resistance syndrome. In Pediatric Medicine, Endocrinology. Neish SR (ed). 2012
11. Karaflou M, Charmandari E, Sertedaki A, Chrousos GP. Familial or sporadic adrenal hypoplasia syndromes. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2012
10. Nicolaides N, Charmandari E, Chrousos GP. Adrenal insufficiency. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2012
9. Charmandari E, Kino T, Chrousos GP. Glucocorticoid resistance syndrome. In Pediatric Medicine, Endocrinology. Neish SR (ed). 2010
8. Kino T, Charmandari E, Vottero A. Glucocorticoid Resistance Syndromes and States. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2010
7. Kino T, Charmandari E, Chrousos GP. Glucocorticoid Receptor. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2010
6. Charmandari E, Kino T, Chrousos GP. Molecular mechanisms of glucocorticoid action. In Orpha.net 2004
5. Charmandari E, Kino T, Chrousos GP. Familial/Sporadic glucocorticoid resistance. In Orpha.net 2004
4. Charmandari E, Kino T, Chrousos GP. Glucocorticoid resistance syndrome. In Pediatric Medicine, Endocrinology. Neish SR (ed). 2003
3. Charmandari E, Chrousos GP. Adrenal insufficiency. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2003; Chapter 13
2. Kino T, Charmandari E, Chrousos GP. Glucocorticoid Receptor. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2003; Chapter 6
1. Kino T, Charmandari E, Chrousos GP. Glucocorticoids: synthesis, action, physiology. In Endotext: Adrenal Disease and Function. Leslie DeGroot (ed). 2003; Chapter 2
Professor Evangelia Charmandari@2020. All rights reserved
Created with ❤️by E-Reputation
Προσωπικά δεδομένα που επεξεργαζόμαστε: Στα πλαίσια της διαχείρισης της ιστοσελίδας επεξεργάζονται τα εξής προσωπικά δεδομένα του επισκέπτη /χρήστη: το ονοματεπώνυμο , το προσωπικό τηλέφωνο /κινητό , το ηλεκτρονικό ταχυδρομείο , στοιχεία τα οποία είναι απολύτως απαραίτητα για την εκπλήρωση του σκοπού της ιστοσελίδας και ειδικότερα την επαφή με το επισκέπτη /χρήστη από την πλευρά του διαχειριστή της ιστοσελίδας μέσω ηλεκτρονικού μηνύματος . Συλλέγουμε ευαίσθητα προσωπικά δεδομένα μόνο όταν τα εν λόγω άτομα μας τα προσφέρουν οικειοθελώς . Τα ευαίσθητα προσωπικά δεδομένα που συλλέγουμε σχετίζονται με την υγεία λόγω και του περιεχομένου της ιστοσελίδας μας και μόνο για να μπορούμε να αξιολογήσουμε σωστά την κατάσταση για να είμαστε στη θέση να δώσουμε τεκμηριωμένες , επιστημονικές και αξιόλογες απαντήσεις στα ερωτήματα σας . Δικαιώματα Πνευματικής Ιδιοκτησίας Όλο το περιεχόμενο της παρούσας ιστοσελίδας , εκτός των ρητά αναφερόμενων εξαιρέσεων (πνευματικά δικαιώματα τρίτων), που - ενδεικτικά - περιλαμβάνει κείμενα, γραφικά, εικόνες, φωτογραφίες σχέδια, video, ήχους κλπ. αποτελούν πνευματική ιδιοκτησία, κατατεθειμένα σήματα και σήματα υπηρεσιών του ιδιοκτήτη της παρούσας ιστοσελίδας. Προστασία Προσωπικών Δεδομένων Ο διαχειριστής της παρούσας ιστοσελίδας συλλέγει προσωπικά στοιχεία των επισκεπτών/ χρηστών της, μόνο όταν αυτοί οι ίδιοι εκουσίως τα παρέχουν. Προσωπικά στοιχεία είναι τα στοιχεία που μπορούν να χρησιμοποιηθούν για τον προσδιορισμό της ταυτότητας ή την επικοινωνία με κάποιο άτομο καθώς και άλλα στοιχεία που αφορούν το εν λόγω άτομο. Ο διαχειριστής είναι δυνατόν να επεξεργάζεται τμήμα ή το σύνολο των στοιχείων που έχουν αποστείλει οι επισκέπτες/ χρήστες για λόγους στατιστικούς και βελτίωσης των παρεχομένων υπηρεσιών - πληροφοριών του. Ο επισκέπτης/ χρήστης μπορεί να επικοινωνήσει με το διαχειριστή της ιστοσελίδας προκειμένου να διασταυρώσει την ύπαρξη προσωπικού του αρχείου, την διόρθωση αυτού, την αλλαγή του ή την διαγραφή του. Ποια δικαιώματα έχετε στα δεδομένα σας; Τα δικαιώματα τα οποία σας παράσχει η κείμενη νομοθεσία είναι : • Ανάκληση συναίνεσης • Αίτημα πρόσβασης • Διόρθωση προσωπικών δεδομένων • Διαγραφή προσωπικών δεδομένων • Περιορισμός της επεξεργασίας δεδομένων προσωπικού χαρακτήρα • Αίτημα φορητότητας προσωπικών δεδομένων • Αμφισβήτηση της επεξεργασίας δεδομένων προσωπικού χαρακτήρα • Αίτημα σχετικά με την αυτοματοποιημένη λήψη αποφάσεων και τη δημιουργία προφίλ Τα δικαιώματα αυτά μπορείτε να ασκήσετε ανά πάσα στιγμή . Για οποιαδήποτε επικοινωνία με το διαχειριστή της ιστοσελίδας παρακαλούμε να αποστείλετε ηλεκτρονική επιστολή στη διεύθυνση reputation.gr@gmail.com